Literature DB >> 26108665

BH3 domain-independent apolipoprotein L1 toxicity rescued by BCL2 prosurvival proteins.

J F Heneghan1, D H Vandorpe1, B E Shmukler1, J A Giovinazzo, J A Giovinnazo2, J Raper2, D J Friedman1, M R Pollak3, S L Alper4.   

Abstract

The potent trypanolytic properties of human apolipoprotein L1 (APOL1) can be neutralized by the trypanosome variant surface antigen gene product known as serum resistance-associated protein. However, two common APOL1 haplotypes present uniquely in individuals of West African ancestry each encode APOL1 variants resistant to serum resistance-associated protein, and each confers substantial resistance to human African sleeping sickness. In contrast to the dominantly inherited anti-trypanosomal activity of APOL1, recessive inheritance of these two trypanoprotective APOL1 alleles predisposes to kidney disease. Proposed mechanisms of APOL1 toxicity have included BH3 domain-dependent autophagy and/or ion channel activity. We probed these potential mechanisms by expressing APOL1 in Xenopus laevis oocytes. APOL1 expression in oocytes increased ion permeability and caused profound morphological deterioration (toxicity). Coexpression of BCL2 family members rescued APOL1-associated oocyte toxicity in the order MCL1BCLW > BCLXLBCL2A1BCL2. Deletion of nine nominal core BH3 domain residues abolished APOL1-associated toxicity, but missense substitution of the same residues abolished neither oocyte toxicity nor its rescue by coexpressed MCL1. The APOL1 BH3 domain was similarly dispensable for the ability of APOL1 to rescue intact mice from lethal trypanosome challenge. Replacement of most extracellular Na(+) by K(+) also reduced APOL1-associated oocyte toxicity, allowing demonstration of APOL1-associated increases in Ca(2+) and Cl(-) fluxes and oocyte ion currents, which were similarly reduced by MCL1 coexpression. Thus APOL1 toxicity in Xenopus oocytes is BH3-independent, but can nonetheless be rescued by some BCL2 family proteins.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  Xenopus oocyte; apolipoprotein L1; hydrodynamic gene delivery; trypanosome; two-electrode voltage clamp

Mesh:

Substances:

Year:  2015        PMID: 26108665      PMCID: PMC4556898          DOI: 10.1152/ajpcell.00142.2015

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  64 in total

1.  Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function.

Authors:  Lin Chen; Simon N Willis; Andrew Wei; Brian J Smith; Jamie I Fletcher; Mark G Hinds; Peter M Colman; Catherine L Day; Jerry M Adams; David C S Huang
Journal:  Mol Cell       Date:  2005-02-04       Impact factor: 17.970

2.  Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy.

Authors:  Sophie Pattingre; Amina Tassa; Xueping Qu; Rita Garuti; Xiao Huan Liang; Noboru Mizushima; Milton Packer; Michael D Schneider; Beth Levine
Journal:  Cell       Date:  2005-09-23       Impact factor: 41.582

3.  Apolipoprotein L-I promotes trypanosome lysis by forming pores in lysosomal membranes.

Authors:  David Pérez-Morga; Benoit Vanhollebeke; Françoise Paturiaux-Hanocq; Derek P Nolan; Laurence Lins; Fabrice Homblé; Luc Vanhamme; Patricia Tebabi; Annette Pays; Philippe Poelvoorde; Alain Jacquet; Robert Brasseur; Etienne Pays
Journal:  Science       Date:  2005-07-15       Impact factor: 47.728

4.  A VSG expression site-associated gene confers resistance to human serum in Trypanosoma rhodesiense.

Authors:  H V Xong; L Vanhamme; M Chamekh; C E Chimfwembe; J Van Den Abbeele; A Pays; N Van Meirvenne; R Hamers; P De Baetselier; E Pays
Journal:  Cell       Date:  1998-12-11       Impact factor: 41.582

5.  Heteromeric channel formation and Ca(2+)-free media reduce the toxic effect of the weaver Kir 3.2 allele.

Authors:  S J Tucker; M Pessia; A J Moorhouse; F Gribble; F M Ashcroft; J Maylie; J P Adelman
Journal:  FEBS Lett       Date:  1996-07-29       Impact factor: 4.124

6.  Metabolic regulation of oocyte cell death through the CaMKII-mediated phosphorylation of caspase-2.

Authors:  Leta K Nutt; Seth S Margolis; Mette Jensen; Catherine E Herman; William G Dunphy; Jeffrey C Rathmell; Sally Kornbluth
Journal:  Cell       Date:  2005-10-07       Impact factor: 41.582

7.  Human trypanolytic factor APOL1 forms pH-gated cation-selective channels in planar lipid bilayers: relevance to trypanosome lysis.

Authors:  Russell Thomson; Alan Finkelstein
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-17       Impact factor: 11.205

8.  Molecular mechanisms of interaction of rabbit CAP18 with outer membranes of gram-negative bacteria.

Authors:  T Gutsmann; J W Larrick; U Seydel; A Wiese
Journal:  Biochemistry       Date:  1999-10-12       Impact factor: 3.162

9.  Apolipoprotein l6, a novel proapoptotic Bcl-2 homology 3-only protein, induces mitochondria-mediated apoptosis in cancer cells.

Authors:  Zhihe Liu; Huimei Lu; Zeyu Jiang; Andrzej Pastuszyn; Chien-an A Hu
Journal:  Mol Cancer Res       Date:  2005-01       Impact factor: 5.852

10.  Beauvericin activates Ca2+-activated Cl- currents and induces cell deaths in Xenopus oocytes via influx of extracellular Ca2+.

Authors:  Chih-Yung Tang; Yi-Wen Chen; Guey-Mei Jow; Cheng-Jen Chou; Chung-Jiuan Jeng
Journal:  Chem Res Toxicol       Date:  2005-05       Impact factor: 3.739

View more
  24 in total

Review 1.  ApoL1 and the Immune Response of Patients with Systemic Lupus Erythematosus.

Authors:  Ashira D Blazer; Robert M Clancy
Journal:  Curr Rheumatol Rep       Date:  2017-03       Impact factor: 4.592

Review 2.  APOL1: The Balance Imposed by Infection, Selection, and Kidney Disease.

Authors:  Pazit Beckerman; Katalin Susztak
Journal:  Trends Mol Med       Date:  2018-06-07       Impact factor: 11.951

3.  Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice.

Authors:  Pazit Beckerman; Jing Bi-Karchin; Ae Seo Deok Park; Chengxiang Qiu; Patrick D Dummer; Irfana Soomro; Carine M Boustany-Kari; Steven S Pullen; Jeffrey H Miner; Chien-An A Hu; Tibor Rohacs; Kazunori Inoue; Shuta Ishibe; Moin A Saleem; Matthew B Palmer; Ana Maria Cuervo; Jeffrey B Kopp; Katalin Susztak
Journal:  Nat Med       Date:  2017-02-20       Impact factor: 53.440

4.  ApoL1 Overexpression Drives Variant-Independent Cytotoxicity.

Authors:  John F O'Toole; William Schilling; Diana Kunze; Sethu M Madhavan; Martha Konieczkowski; Yaping Gu; Liping Luo; Zhenzhen Wu; Leslie A Bruggeman; John R Sedor
Journal:  J Am Soc Nephrol       Date:  2017-11-27       Impact factor: 10.121

5.  Apolipoprotein L-1 renal risk variants form active channels at the plasma membrane driving cytotoxicity.

Authors:  Joseph A Giovinazzo; Russell P Thomson; Nailya Khalizova; Patrick J Zager; Nirav Malani; Enrique Rodriguez-Boulan; Jayne Raper; Ryan Schreiner
Journal:  Elife       Date:  2020-05-19       Impact factor: 8.140

Review 6.  Systemic and renal lipids in kidney disease development and progression.

Authors:  Patricia Wahl; Gloria Michelle Ducasa; Alessia Fornoni
Journal:  Am J Physiol Renal Physiol       Date:  2015-12-23

Review 7.  The Cell Biology of APOL1.

Authors:  John F O'Toole; Leslie A Bruggeman; Sethu Madhavan; John R Sedor
Journal:  Semin Nephrol       Date:  2017-11       Impact factor: 5.299

Review 8.  APOL1 Nephrotoxicity: What Does Ion Transport Have to Do With It?

Authors:  Opeyemi A Olabisi; John F Heneghan
Journal:  Semin Nephrol       Date:  2017-11       Impact factor: 5.299

Review 9.  APOL1 Kidney Disease Risk Variants: An Evolving Landscape.

Authors:  Patrick D Dummer; Sophie Limou; Avi Z Rosenberg; Jurgen Heymann; George Nelson; Cheryl A Winkler; Jeffrey B Kopp
Journal:  Semin Nephrol       Date:  2015-05       Impact factor: 5.299

Review 10.  Apolipoprotein L1 and Kidney Disease in African Americans.

Authors:  David J Friedman; Martin R Pollak
Journal:  Trends Endocrinol Metab       Date:  2016-03-03       Impact factor: 12.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.